Growth, clonability, and radiation resistance of esophageal carcinoma-derived stem-like cells

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 8, 2013, Pages 4891-4896

  Li, Jian Cheng ^a   Liu, Di ^b   Yang, Yan ^a   Wang, Xiao Ying ^a   Pan, Ding Long ^a   Qiu, Zi Dan ^a   Su, Ying ^a   Pan, Jian Ji ^a  

^a FUJIAN PROVINCIAL TUMOR HOSPITAL   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

CD44; Esophageal carcinoma; Tumor stem like cells

Indexed keywords

HERMES ANTIGEN;

ARTICLE; CANCER STEM CELL; CELL ADHESION; CELL CLONE; CELL PROLIFERATION; CELL SEPARATION; CFU COUNTING; ESOPHAGUS TUMOR; FLOW CYTOMETRY; GAMMA RADIATION; HUMAN; METABOLISM; PATHOLOGY; RADIATION DOSE; RADIATION EXPOSURE; TUMOR CELL CULTURE;

ANTIGENS, CD44; CELL ADHESION; CELL PROLIFERATION; CELL SEPARATION; CLONE CELLS; COLONY-FORMING UNITS ASSAY; ESOPHAGEAL NEOPLASMS; FLOW CYTOMETRY; GAMMA RAYS; HUMANS; NEOPLASTIC STEM CELLS; RADIATION TOLERANCE; TUMOR CELLS, CULTURED;

EID: 84885715957     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.8.4891     Document Type: Article

References (36)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A, 100, 3983-8.
2. Atsushi S, Masahito N, Hitomi A, et al (2006). Characterization of CD133 hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun, 351, 820-4.
3. Bentivegna A, Conconi D, Panzeri E (2010). Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples. Cancer Sci, 101, 416-24.
4. Cheng L, Ramesh AV, Flesken-Nikitin A, et al (2010). Mouse models for cancer stem cell researchl. Toxicol Patho, 38, 62-71.
5. Collins AT, Berry PA, Hyde C, et al (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res, 65, 10946-51.
6. Dalerba P, Dylla SJ (2007). Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A, 104, 10158-63.
7. Dontu G, Abdallah WM, Foley JM, et al (2003). In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev, 17, 1253-70.
8. Elena M, Floriana F, Enrico G, et al (2007). Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer, 43, 935-46.
9. Eyler CE, Rich JN (2008). Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol, 26, 2839-45.
10. Freedman VH, Shin SI (1974). Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell, 3, 355-9.
11. Hayashi S, Fujita K, Matsumoto S, et al (2011). Isolation and identification of cancer stem cells from a side population of a human hepatoblastoma cell line, HuH-6 clone-5. Pediatr Surg Int, 27, 9-16.
12. Houghton J, Stoicov C, Nomura S, et al (2004). Gastric cancer originating from bone marrow-derived cells. Science, 306, 1568-71.
13. Jun M, Bungo F, Hongzhen Li, et al (2007). Identification of putative stem cell markers, CD133 and CXCR4, in Htert-immoralized primary nonmalignent and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res, 67, 3153-61.
14. Kondo T, Setoguchi T, Taga T (2004). Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A, 101, 781-6.
15. Kordes C, Häussinger D (2013). Hepatic stem cell niches. J Clin Invest, 123, 1874-80.
16. Lapidot T, Sirard C, Vormoor J, et al (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 367, 645-8.
17. Li C, Heidt DG, Dalerba P, et al (2007). Identification of pancreatic cancer stem cells. Cancer Res, 63, 1031-7.
18. Monika O, Patricia A, Ole A, et al (2007). Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Lin, 6, 92-7.
19. Noh MS, Jun BH, Kim S, et al (2009). Magnetic surface-enhanced Raman spectroscopic (M-SERS) dots for the identification of bronchioalveolar stem cells in normal and lung cancer mice. Biomaterials, 30, 3915-25.
20. Okumttra T, Shimada Y, Imamura M, et al (2003). Neurotrophin receptor p75(NTR) characterizes human esophageal keratinceyte stem cells invitro. Oneogene, 22, 4017-26.
21. Patrawala L,Calhoun T,Schneider-Broussard R, et al (2005). Side population is enriched in tumorigenic,stem-like cancer cells,whereas ABCG2+ and ABCG-cancer cells are similarly tumorigenic. Cancer Res, 65, 6207-19.
22. Perez-Losada J, Balmain A (2003). Stem-cell hierarchy in skin cancer. Nat Rev Cancer, 3, 434-43.
23. Pérez Mdel C, López A, Padilla P (2013). Space-time dynamics of Stem Cell Niches: a unified approach for Plants. J Integr Bioinform, 10, 219.
24. Ponti D, Costa A, Zaffaroni N, et al (2005). Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res, 65, 5506-11.
25. Reya T, Morrison SJ, Clarke MF, et al (2001). Stem cells, cancer and cancer stem cells. Nature, 414, 105-11.
26. Rahman R, Heath R, Grundy R, et al (2009). Cellular immortality in brain tumor: an integration of the cancer stem cell paradigm. Biochim Biophys Acta, 1792, 280-8.
27. Richardson GD, Robson CN, Lang SH, et al (2004). CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci, 117, 3539-45.
28. Rich JN (2007). Cancer stem cells in radiation resistance. Cancer Res, 67, 8980-4.
29. Singh SK, Clarke ID, Hide T, et al (2004). Cancer stem cell in nervous system tumors. Oncogene, 23, 7267-73.
30. Singh SK, Clarke ID, Terasaki M, et al (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res, 63, 5821-8.
31. Singh SK, Hawkins C, Clarke ID, et al (2004). Identification of human brain tumor initiating cells. Nature, 432, 396-401.
32. Seigel GM, Campbell LM, Narayan M, et al (2005). Cancer stem cell characteristics in retinoblastoma. Mol Vis, 11, 729-37.
33. Setoguchi T, Taga T, Kondo T (2004). Cancer stem cells persist in many cancer cell lines. Cell Cycle, 3, 414-5.
34. Smith PJ, Furon E, Wiltshire M, et al (2009). ABCG2-associated resistance to Hoechst 33342 and topotecan in a murine cell model with constitutive expression of side population characteristics. Cytometry A, 75, 924-33.
35. Taylor MD, Poppleton H, Fuller C, et al (2005). Radial glia cells are candidate stem cells of ependymoma. Cancer Cell, 8, 323-35.
36. Toivanen R, Berman DM, Wang H (2011). Brief report: a bioassay to identify primary human prostate cancer repopulating cells. Stem Cell, 29, 1310-4.